Načítá se...
Cost analysis of tuberculosis diagnosis in Cambodia with and without Xpert® MTB/RIF for people living with HIV/AIDS and people with presumptive multidrug-resistant tuberculosis
BACKGROUND: The Xpert® MTB/RIF (Xpert) test has been shown to be effective and cost-effective for diagnosing tuberculosis (TB) under conditions with high HIV prevalence and HIV-TB co-infection but less is known about Xpert’s cost in low HIV prevalence settings. Cambodia, a country with low HIV preva...
Uloženo v:
| Vydáno v: | Appl Health Econ Health Policy |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050005/ https://ncbi.nlm.nih.gov/pubmed/29862440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-018-0397-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|